Liver alanine catabolism promotes skeletal muscle atrophy and hyperglycaemia in type 2 diabetes-Reference-Cited by-同舟云学术

Liver alanine catabolism promotes skeletal muscle atrophy and hyperglycaemia in type 2 diabetes

Published:2021-03 Issue:3 Volume:3 Page:394-409
ISSN:2522-5812
Container-title:Nature Metabolism
language:en
Short-container-title:Nat Metab

Author:

Okun Jürgen G.,Rusu Patricia M.^ORCID,Chan Andrea Y.,Wu Yuqin^ORCID,Yap Yann W.,Sharkie Thomas,Schumacher Jonas,Schmidt Kathrin V.,Roberts-Thomson Katherine M.,Russell Ryan D.,Zota Annika,Hille Susanne,Jungmann Andreas,Maggi Ludovico^ORCID,Lee Young,Blüher Matthias^ORCID,Herzig Stephan^ORCID,Keske Michelle A.,Heikenwalder Mathias^ORCID,Müller Oliver J.^ORCID,Rose Adam J.^ORCID

Funder

MU | Faculty of Medicine, Nursing and Health Sciences, Monash University

Sir Edward ‘Weary' Dunlop Medical Research Foundation

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Physiology (medical),Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://www.nature.com/articles/s42255-021-00369-9.pdf

Reference83 articles.

1. Zamboni, M., Mazzali, G., Fantin, F., Rossi, A. & Di Francesco, V. Sarcopenic obesity: a new category of obesity in the elderly. Nutr. Metab. Cardiovas. Dis. 18, 388–395 (2008).

2. Parr, E. B., Coffey, V. G. & Hawley, J. A. ‘Sarcobesity’: a metabolic conundrum. Maturitas 74, 109–113 (2013).